Xlife Sciences AG (XLS) — Strategic Asset Allocation Index
Xlife Sciences AG (XLS) has a Strategic Asset Allocation Index of 0.1% as of June 2025. Strategic assets (PP&E of CHF210.81K plus long-term investments of CHF-) total CHF210.81K, measured against net assets of CHF303.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Xlife Sciences AG to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Xlife Sciences AG Strategic Asset Allocation Index (2019–2024)
This chart shows how Xlife Sciences AG's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 0.1%, representing strategic assets of CHF210.81K against net assets of CHF303.42 Million CHF. For live market cap and overall valuation, see market value of Xlife Sciences AG.
Annual Strategic Asset Allocation Index for Xlife Sciences AG (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Xlife Sciences AG from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Xlife Sciences AG for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.1% | CHF269.19K | CHF269.19K | CHF- | CHF305.26 Million | ▼ -0.1 pp |
| 2023 | 0.1% | CHF393.67K | CHF393.67K | CHF- | CHF268.17 Million | ▼ -0.1 pp |
| 2022 | 0.2% | CHF535.58K | CHF535.58K | CHF- | CHF235.23 Million | ▼ -0.1 pp |
| 2021 | 0.3% | CHF669.57K | CHF669.57K | CHF- | CHF211.23 Million | ▼ 0.0 pp |
| 2020 | 0.3% | CHF433.41K | CHF433.41K | CHF- | CHF130.17 Million | ▲ +0.1 pp |
| 2019 | 0.3% | CHF270.58K | CHF270.58K | CHF- | CHF97.38 Million | — |